A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Recent news on Equetro

Analysis: Raves for Shire's Vyvance deal - Feb 21, 2007
Science Daily (press release)The sales increase was driven by strong performances from Carbatrol/Equetro, Pentasa, Fosrenol and Elaprase. Shire said it anticipates revenue growth of

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional